Response to "Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas"

Pediatr Dermatol. 2018 Sep;35(5):700. doi: 10.1111/pde.13579.

Authors

Jillian F Rork^{1

2}, Brea Prindaville³, Renata Dalla Costa⁴, Karen Wiss^{1

2}

Affiliations

¹ Department of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA.
² Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA, USA.
³ Department of Dermatology, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
⁴ University of Massachusetts Medical School, Worcester, MA, USA.

PMID: 30211462
DOI: 10.1111/pde.13579

No abstract available

Publication types

Letter
Comment

MeSH terms

Administration, Topical
Adrenergic beta-Antagonists
Hemangioma
Hemangioma, Capillary*
Humans
Infant
Skin Neoplasms
Timolol*
Treatment Outcome

Substances

Adrenergic beta-Antagonists
Timolol